Ardelyx
ARDX
$6.46
Share price
0.62%
Change (1 day)
38.92%
Change (1 year)
Categories
Ardelyx (ARDX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.29 B
According to Ardelyx's latest financial reports the company's total assets are $0.29 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Ardelyx - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.29 B | 56.57% |
| 2022-12-31 | $0.19 B | 26.78% |
| 2021-12-31 | $0.14 B | -25.62% |
| 2020-12-31 | $0.20 B | -22.41% |
| 2019-12-31 | $0.25 B | 41.7% |
| 2018-12-31 | $0.18 B | 16.1% |
| 2017-12-31 | $0.15 B | -25.91% |
| 2016-12-31 | $0.21 B | 82.25% |
| 2015-12-31 | $0.11 B | 3.11% |
| 2014-12-31 | $0.11 B | 164.34% |
| 2013-12-31 | $42.9 M | 13.25% |
| 2012-12-31 | $37.88 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $73.21 B | 24,503.21% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 32,548.14% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 46,884.50% | 🇫🇷 France |
 AstraZeneca AZN | $102.29 B | 34,275.07% | 🇬🇧 UK |
 OPKO Health
OPK | $2.01 B | 576.02% | 🇺🇸 USA |